Saarvienin A—A Novel Glycopeptide with Potent Activity against Drug‐Resistant Bacteria
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202425588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Amninder Kaur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarland Univ…. Hauptthemen laut MEDLINE: Glycopeptides, Anti-Bacterial Agents, Drug Resistance, Bacterial, Gram-Positive Bacteria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Centre for Infection Research, University of Vienna, Saarland University.
Abstract (Originalsprache)
A member of a new family of glycopeptides, named saarvienin A, was isolated from a rare actinomycete Amycolatopsis sp. YIM10. Extensive NMR and MS analyses revealed a halogenated peptide core comprising four amino acids cyclized via a ureido linkage with an exocyclic 2‐hydroxy‐3‐(4‐hydroxyphenyl)propyl residue connected to a five‐sugar/aminosugar chain. Two of the three aminosugars constitute the N ‐methylated and N , O ‐dimethylated derivatives of eremosamine (4‐ epi ‐vancosamine) that have not been reported in any natural product. Saarvienin A exhibits potent activity against a range of Gram‐positive bacteria, effectively overcoming resistance to several frontline antibiotics in clinical isolates. It demonstrates an eight‐fold reduction in minimum inhibitory concentrations (MICs) against methicillin‐resistant, vancomycin‐intermediate, and daptomycin‐resistant Staphylococcus aureus compared to vancomycin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), PharmaScienceHub (PSH), Saarland University Campus, 66123, Saarbrücken, Germany.
- German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, 38124, Braunschweig, Germany.
- Department of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Vienna, 1090, Austria.
- Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, 1090, Austria.
- Department of Chemistry, Saarland University, 66123, Saarbrücken, Germany.
- Department of Pharmacy, Saarland University, 66123, Saarbrücken, Germany.
Förderung
- German Centre for Infection Research
- University of Vienna
- Saarland University
- German Science Foundation
- Universität Wien
- Universität des Saarlandes
Zitieren
APA
Kaur, A., Guerrero-Garzón, J. F., Rasheed, S., Zehl, M., Fries, F., Morgenstern, B., Zotchev, S. B., & Müller, R. (2025). Saarvienin A—A Novel Glycopeptide with Potent Activity against Drug‐Resistant Bacteria. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202425588
Vancouver
Kaur A, Guerrero-Garzón JF, Rasheed S, Zehl M, Fries F, Morgenstern B, et al. Saarvienin A—A Novel Glycopeptide with Potent Activity against Drug‐Resistant Bacteria. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202425588
BibTeX
@article{Kaur2025,
author = {Kaur, Amninder and Guerrero-Garzón, Jaime Felipe and Rasheed, Sari and Zehl, Martin and Fries, Franziska and Morgenstern, Bernd and Zotchev, Sergey B and Müller, Rolf},
title = {Saarvienin A—A Novel Glycopeptide with Potent Activity against Drug‐Resistant Bacteria},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202425588}
}
EUVIMED